X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.240
+0.040 (1.25%)
At close: Oct 23, 2026, 4:00 PM EDT
3.250
+0.010 (0.31%)
After-hours: Oct 23, 2026, 7:30 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $321.24 million as of October 23, 2026. It is the 17,622nd most valuable company in the world and the 3,109th biggest in the United States. Its market cap has increased by 361.58% in one year.
Market Cap
321.24M
Enterprise Value
190.49M
1-Year Change
361.58%
Global Rank
Country Rank
#3,109 United States
Category
ChartMarket Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $321.24M, an increase of 215.64%. That is a compound annual growth rate of 16.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 321.24M | -8.15% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 317.30M |
| Arcturus Therapeutics Holdings | 314.64M |
| Contineum Therapeutics | 314.14M |
| Vogenx | 302.90M |
| Turn Therapeutics | 302.35M |
| Inhibikase Therapeutics | 302.24M |
| Surrozen | 297.60M |
| Benitec Biopharma | 296.50M |